Cargando…

Cefazolin Pharmacokinetics in Premature Infants

OBJECTIVE: Pharmacokinetic (PK) data to guide cefazolin dosing in premature infants is virtually non-existent. Therefore, we aimed to characterize cefazolin PK in infants aged ≤32 weeks of gestation at birth. STUDY DESIGN: We conducted a prospective, open-label PK and safety study of cefazolin in in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balevic, Stephen J., Smith, P. Brian, Testoni, Daniela, Wu, Huali, Brouwer, Kim L.R., Zimmerman, Kanecia O., Rivera-Chaparro, Nazario D., Benjamin, Daniel K., Cohen-Wolkowiez, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713589/ https://www.ncbi.nlm.nih.gov/pubmed/30944398 http://dx.doi.org/10.1038/s41372-019-0368-z

Ejemplares similares

Ampicillin Dosing in Premature Infants for Early-onset Sepsis: Exposure-driven Efficacy, Safety, and Stewardship
por: Le, Jennifer, et al.
Publicado: (2022)

Wide variation in caffeine discontinuation timing in premature infants
por: Ji, Dabin, et al.
Publicado: (2019)

565. Pilot Study of Prolonged Post-Discontinuation Antibiotic Exposure (PDAE) to Ampicillin Among Low Birthweight Preterm Infants
por: Boutzoukas, Angelique E, et al.
Publicado: (2022)

Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trial
por: Balevic, Stephen J, et al.
Publicado: (2022)

Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial
por: Lang, Jason E., et al.
Publicado: (2022)

Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO
por: Watt, Kevin M., et al.
Publicado: (2018)

Population pharmacokinetic model of cefazolin in total hip arthroplasty
por: Lanoiselée, J., et al.
Publicado: (2021)

Wide range of perioperative drugs and doses used in inguinal hernia repairs for premature infants
por: Dorismond, Christina, et al.
Publicado: (2020)

Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients
por: Novak, Alison R, et al.
Publicado: (2021)

Pharmacokinetics and Optimal Dose Selection of Cefazolin for Surgical Prophylaxis of Pediatric Patients
por: Schmitz, Michael L., et al.
Publicado: (2020)

Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery
por: Alli, Ahmad, et al.
Publicado: (2023)

An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants
por: Thakkar, Nilay, et al.
Publicado: (2016)

Population Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone in Neonates Undergoing Cardiopulmonary Bypass
por: Hornik, Christoph P., et al.
Publicado: (2019)

Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions
por: Balevic, Stephen J., et al.
Publicado: (2022)

Safety of sildenafil in extremely premature infants: a phase I trial
por: Jackson, Wesley, et al.
Publicado: (2021)

Association of Antibiotic Duration and Outcomes among NICU Infants with Invasive Staphylococcus aureus Infections
por: Bukhari, Areej, et al.
Publicado: (2021)

Association between simulated ketamine exposures and oxygen saturations in children
por: Commander, Sarah Jane, et al.
Publicado: (2023)

Estimation of Body Fat Percentage for Clinical Pharmacokinetic Studies in Children
por: Green, Thomas P., et al.
Publicado: (2020)

Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy
por: van Hasselt, J. G. Coen, et al.
Publicado: (2014)

Rational dosage regimens for cephalothin and cefazolin using pharmacokinetics and pharmacodynamics analysis in healthy horses
por: Kuroda, Taisuke, et al.
Publicado: (2021)

Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation
por: Šantavý, Petr, et al.
Publicado: (2022)

Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents
por: Ge, Shufan, et al.
Publicado: (2020)

Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial
por: Randell, Rachel L, et al.
Publicado: (2021)

Corrigendum to “Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy”
por: van Hasselt, J. G. Coen, et al.
Publicado: (2015)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
por: Cagnardi, Petra, et al.
Publicado: (2018)

Is it just a cefazolin issue?
por: Takazawa, Tomonori, et al.
Publicado: (2019)

Cefazolin and an aminoglycoside compared with cefazolin alone for the antimicrobial prophylaxis of type III open orthopedic fractures
por: Depcinski, Shawn C., et al.
Publicado: (2019)

Physiologically‐Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants
por: Gerhart, Jacqueline G., et al.
Publicado: (2019)

The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery
por: Douglas, Alexandra, et al.
Publicado: (2011)

Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI)
por: So, Wonhee, et al.
Publicado: (2014)

Prevention of Surgical Site Infections and Biofilms: Pharmacokinetics of Subcutaneous Cefazolin and Metronidazole in a Tumescent Lidocaine Solution
por: Klein, Jeffrey A., et al.
Publicado: (2017)

Comparison the Efficacy of Cefazolin plus Gentamicin with Cefazolin plus Ciprofloxacin in Management of Type –IIIA Open Fractures
por: Janmohammadi, N, et al.
Publicado: (2011)

Pediatric Trials Network: Stakeholder views on thanking families and providing study findings on pragmatic pediatric clinical research
por: Corneli, Amy, et al.
Publicado: (2021)

Cefazolin as a cause of leukocytoclastic vasculitis
por: Ali, Naveed, et al.
Publicado: (2017)

Cefazolin Plus Ceftazidime versus Cefazolin Monotherapy in the Treatment of Culture-Negative Peritonitis: A Retrospective Cohort Study
por: Kovitangkoon, Krit, et al.
Publicado: (2022)

Using Pharmacokinetic Modeling and Electronic Health Record Data to Predict Clinical and Safety Outcomes after Methylprednisolone Exposure during Cardiopulmonary Bypass in Neonates
por: Foote, Henry P., et al.
Publicado: (2023)

Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes
por: Balevic, Stephen J, et al.
Publicado: (2022)

Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial
por: Fidler, Matthew, et al.
Publicado: (2020)

Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants
por: Curtis, Samantha, et al.
Publicado: (2023)

Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
por: Gern, Benjamin H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aqj8b9bg868lfurqqmrrcg3cm5